Litcius/Paper detail

Patient-Reported Symptom and Functioning Status during the First 12 Months after Chimeric Antigen Receptor T Cell Therapy for Hematologic Malignancies

Xin Shelley Wang, Samer A. Srour, Meagan Whisenant, Ishwaria M. Subbiah, Tsun Hsuan Chen, Darcy Ponce, Araceli García-González, Mona Kamal, Tito R. Mendoza, Charles S. Cleland, Partow Kebriaei, Sattva S. Neelapu, Katayoun Rezvani, Sairah Ahmed, Elizabeth J. Shpall

2021Transplantation and Cellular Therapy61 citationsDOIOpen Access PDF

Topics & Concepts

MedicineChimeric antigen receptorInternal medicineQuality of life (healthcare)Observational studyCytokine release syndromeOncologyCancerPhysical therapyImmunotherapyNursingCAR-T cell therapy researchSafe Handling of Antineoplastic Drugs
Patient-Reported Symptom and Functioning Status during the First 12 Months after Chimeric Antigen Receptor T Cell Therapy for Hematologic Malignancies | Litcius